Efficacy of parenteral itraconazole against disseminated Candida albicans infection in two mouse strains

Donna Margaret MacCallum, Frank Christopher Odds

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The efficacy of a new cyclodextrin intravenous formulation of itraconazole was evaluated by intraperitoneal treatment of experimental disseminated Candida albicans infections in BALB/c and DBA/2 mice. Mice were treated with doses of 5 or 20 mg/kg for 14 days and observation was continued for 28 days. Mice were randomly assigned to groups given either water or grapefruit juice as drinking fluid, since components of grapefruit juice that inhibit cytochrome P450 enzymes might influence the pharmacokinetic behaviour of itraconazole. The experiments showed that the itraconazole/cyclodextrin solution unequivocally prolonged survival and reduced weight loss over the first 4 days post-challenge, relative to placebo-treated control animals, in both mouse strains. However, the antifungal treatments did not reduce burdens of C. albicans in kidneys or brain. Placebo-treated DBA/2 mice given grapefruit juice to drink had a significantly shorter mean survival time than the equivalent group given water. In BALB/c mice the placebo-treated animals given grapefruit juice survived longer, though not significantly longer, than placebo-treated animals given water. These results give a preliminary hint that grapefruit juice alters the susceptibility of some mouse strains to C. albicans infection, regardless of any effects or non-effects it may have on itraconazole pharmacokinetics in the animals.

Original languageEnglish
Pages (from-to)225-229
Number of pages5
JournalJournal of Antimicrobial Chemotherapy
Volume50
Issue number2
DOIs
Publication statusPublished - 2002

Keywords

  • amphotericin-B
  • invasive aspergillosis
  • oral itraconazole
  • antifungal agents
  • in-vitro
  • cyclodextrin
  • voriconazole
  • fluconazole
  • mycoses
  • vivo

Cite this